AIM
PRQR icon

Axiom Investment Management’s ProQR Therapeutics PRQR Stock Holding History

Axiom Investment Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.5K Buy
+33,000
New +$54.1K 0.04% 203
2022
Q4 		– Sell
-4,500
Closed -$3K – 334
2022
Q3 		$3K Buy
+4,500
New +$3.61K 0.01% 320

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Axiom Investment Management's PRQR Position: Q1 2026 in Review

Axiom Investment Management opened a new position in ProQR Therapeutics (PRQR) in Q1 2026: 33,000 shares worth $53.5K. The stake represents 0.04% of the portfolio and ranks #203 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in PRQR as recently as Q3 2022.

Axiom Investment Management first reported a position in PRQR in Q3 2022 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • Axiom Investment Management held 33,000 shares of ProQR Therapeutics worth $53.5K as of Q1 2026.
  • ProQR Therapeutics was a new Axiom Investment Management position in Q1 2026.
  • ProQR Therapeutics made up 0.04% of Axiom Investment Management's portfolio in Q1 2026, its #203 holding.
  • Axiom Investment Management first reported a position in ProQR Therapeutics in Q3 2022 and has held it in 2 quarters since.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on Axiom Investment Management's 13F filing for Q1 2026, filed 26 May 2026.